Journal
CLINICAL CASE REPORTS
Volume 8, Issue 1, Pages 24-32Publisher
WILEY
DOI: 10.1002/ccr3.2534
Keywords
aseptic meningitis; checkpoint inhibitor; encephalitis; ipilimumab; neurotoxicity; nivolumab
Categories
Funding
- Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health
- NATIONAL CANCER INSTITUTE [ZIABC011351, ZIEBC011384] Funding Source: NIH RePORTER
Ask authors/readers for more resources
We report a case of nivolumab-induced delayed-onset aseptic meningitis and a case of limbic encephalitis and peripheral nerve palsy with toxicity relapse 6 months after initial presentation. The atypical presentations contribute to our knowledge of these rare events and reinforce the necessity for vigilant monitoring and a multidisciplinary treatment approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available